Qualcomm Gains Modestly After Arm Verdict, While Huawei Licensing Deal Marks Strategic Shift

Qualcomm (ticker QCOM) shares rose approximately 1% following a Delaware jury’s finding on October 13, 2026 that Arm Holdings breached a licensing agreement and interfered with Qualcomms business dealings with Meta Platforms, marking a legal win for the chipmaker despite nominal damages awarded. Meanwhile, earlier in the week, Qualcomm and Huawei struck a pivotal multi-year patent licensing agreement spanning 5G, AI, compute and networking technologies, indicating a strategic pivot in their longstanding relationship.

Jury Verdict Offers Legal Clarity and Minor Market Boost

On October 13, 2026, a federal jury in Wilmington, Delaware determined that Arm Holdings had violated its architectural license agreement with Qualcomm and intentionally disrupted Qualcomms business with Meta Platforms. The jury awarded Qualcomm just $2 in nominal damages. Nonetheless, Qualcomm framed the ruling as a victory for innovation and competition. The verdict followed a five-day trial and comes amid a deteriorating relationship between the two firms since Arm’s shift from licensing to manufacturing under SoftBanks ownership. Qualcomm shares gained around 1% on the news, though Arm’s stock declined by a similar amount.

This verdict helps clarify Qualcomms ability to advance its custom Oryon CPU development, reducing some operational risk, even though financial gains from the decision are minimal. It also underscores the ongoing tension between client chipmakers and architecture licensors in the industry amid evolving business models.

Landmark Cross‑Licensing Deal with Huawei

Earlier in the week, on October 5, 2026, Qualcomm and Huawei announced a broad, multi-year patent licensing agreement. The deal covers domains spanning artificial intelligence, 5G, computing and networking technologies. As part of the agreement, Qualcomm will purchase certain Huawei U.S. patents outright.

This marks Qualcomms first-ever 5G patent licensing deal with Huawei and signifies a strategic shift—Qualcomm will now pay Huawei under this cross‑licensing framework, something that had not occurred previously. Huawei expects the agreement to bring its total licensing income past $6.9 billion once fully implemented. The arrangement reflects both companies’ commitment to fair, reasonable and non-discriminatory (FRAND) licensing standards.

Why These Developments Matter

The legal ruling against Arm, while financially symbolic, provides Qualcomm with greater clarity and freedom to pursue its Oryon CPU strategy—central to its push into custom silicon and data-center applications. Legal conflicts over licensing and chip-testing tools had complicated this ambition, making the verdict a noteworthy strategic relief.

Separately, the Huawei agreement represents a major evolution in Qualcomms patent monetization. After years of Huawei licensing Qualcomms intellectual property, the dynamic has flipped. Now, Qualcomm will compensate Huawei for broader IP access. This could restore some lost revenue and forge more stable terms in a critical technology domain—especially amid heightened geopolitical tensions and supply-chain disruptions.

Looking Ahead

Investors should monitor whether Qualcomm sees material revenue from the Huawei licensing deal, including the timing of payments and impact on margins. The company may also be better positioned to expand its custom CPU roadmap, including Oryon, now that one legal hurdle has cleared. On the litigation front, attention will likely turn to whether Qualcomm attempts to further limit royalty obligations to Arm, potentially saving billions in future payments.

Together, these developments mark a week of significant repositioning for Qualcomm—offering both legal validation and commercial realignment that could shape its medium-term strategy in AI, 5G and custom silicon.